Ongoing monitoring for women on ERT includes:
1. Lipid levels, repeated annually if abnormal
2. Annual health history and review of risk profile
3. Annual mammogram
4. All of the above
4
You might also like to view...
A patient who is having an acute exacerbation of multiple sclerosis has a prescription for methylprednisolone (Solu-Medrol) 160 mg IV. The label on the vial reads: methylprednisolone 125 mg in 2 mL. How many mL will the nurse administer?
What will be an ideal response?
The nurse is providing care to a patient with tuberculosis who is taking ethambutol (Myambutol). Which statement by the patient indicates a correct understanding of the effects of ethambutol?
a. "Dizziness, drowsiness, and decreased urinary output are common with this drug, but they will subside over time." b. "Constipation will be a problem, so I will increase the fiber in my diet." c. "I will need to have my eyes checked periodically while I am taking this drug." d. "This medication may cause my bodily secretions to turn bluish green."
When assessing pain in a child, the nurse needs to be aware of which of the following considerations:
a. Immature neurologic development results in reduced sensation of pain. b. Inadequate or inconsistent relief of pain is widespread. c. Reliable assessment tools are currently unavailable. d. Narcotic analgesic use should be avoided
A patient has been on opioids for 3 months to control pain caused by injuries from a motor vehicle crash. The patient asks about the risk of withdrawal symptoms when the drugs are no longer needed. How should the nurse respond to the patient?
a. "Ask your doctor for a sedative to get you through the worst of the withdrawal symptoms." b. "As long as you taper the drug dose down slowly, you should not experience withdrawal symptoms." c. "You would have to be on these drugs much longer than 3 months to have problems with withdrawal." d. "You were using the drugs for legitimate pain, so you will not have to go through withdrawal when you stop them."